NS-001 (Wuhan iRegene Pharmaceutical Technology)

N/A

Report date: 2025/03/20 10:01:44

Base Information

Drug NameNS-001 (Wuhan iRegene Pharmaceutical Technology)
Drug Alias NameNS-001 (iRegene Therapeutics)cell therapy (Wuhan iRegene Pharmaceutical Technology)NS-001
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesiRegene Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesiRegene Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic Retinopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A